• English
  • Korean
  • Chinese
市場調査レポート - 236763

遺伝子検査の世界市場

Genetic Testing

発行 Global Industry Analysts, Inc.
出版日 ページ情報 英文 375 Pages
価格

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。 PDFのダウンロード・閲覧には Adobe Digital Editions が必要となります。ご購入頂いた場合、同Adobe Digital Editions (ご購入時無償配布)をPCにインストールして頂き、ダウンロードを行ったPC上のみでの閲覧と、1回のプリントアウトが可能となっております。ご不明な点につきましてはお問合せください。

遺伝子検査の世界市場 Genetic Testing
出版日: 2012年02月01日 ページ情報: 英文 375 Pages
概要

当レポートでは、世界の遺伝子検査市場について調査分析を行い、出生前遺伝子検査、新生児遺伝子検査、薬理ゲノミクス検査、予測検査の各製品部門にまとめるとともに、米国、カナダ、日本、欧州、世界のその他の諸国の各市場について包括的に分析し、2009年〜2017年の見通し、過去6年間の実績などについてまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション、調査方法、製品の定義

第2章 エグゼクティブサマリー

  • 概要
    • サービス主導から製品主導の市場へ
    • 遺伝子検査:分子診断市場の急成長部門
    • 遺伝子検査の見通しは明るい
    • 市場に影響を及ぼす課題と動向
    • 直面する課題
    • 遺伝カウンセリング
    • オンラインによるアプローチ
    • 成人期発症疾患のスクリーニングにおける小児遺伝子検査の普及
    • ACOGとACGMの勧告がCF検査の需要を拡大
    • 倫理問題と適切な規制方針の必要
    • 日常的臨床検査と予測的遺伝子検査
    • 肥満の遺伝子検査に関する問題
    • 妊娠期の診断と治療−梅毒関連の死亡や死産を減らす有効な方法
    • 競合
  • 製品の概要
    • 遺伝子検査の概要
    • 遺伝子検査とその応用
    • 候補遺伝子とゲノムスクリーニング
    • DNAチップ
    • 遺伝子変化を特定する技術
    • 遺伝子検査の種類
    • 遺伝子検査過程の段階
    • 制限
    • 遺伝子検査のリスクとその他の制限
    • 遺伝子検査の恩恵を受ける医療機関
    • 薬理遺伝学/薬理ゲノミクス
    • 主な遺伝子検査
    • 嚢胞性線維症
    • 乳癌/卵巣癌
    • アルツハイマー病
    • 結腸直腸癌
    • ヘモクロマトーシス(HH)
    • コーデン症候群
    • ハンチントン病
    • 主な検査の費用
  • 製品の発売
  • 製品の導入と革新‐見通し
  • 最近の産業活動
  • 企業の戦略的発展−見通し
  • 技術の発展−見通し
  • 世界の主要企業
  • 世界市場の概要

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • 世界のその他の諸国

第4章 競合状況

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Description

This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 76 Companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, ELITech Group, PerkinElmer, Inc., Quest Diagnostics, Inc., Roche Diagnostics Corp., Roche Molecular Diagnostics, Inc., and Transgenomic, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Prenatal Diagnosis
    • Newborn Screening
    • Pharmacogenetics/Pharmacogenomics
    • Predictive Testing

II. EXECUTIVE SUMMARY

1. OVERVIEW

  • Progressing from Service Driven to Product-Driven Market
  • Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market
    • Table 1: Worldwide In-Vitro Diagnostics Market by Segment (2008) - Percentage Breakdown of Value Sales for Immunochemistry, Diabetes, Clinical Chemistry, Point-of-Care Testing, Molecular Diagnostics, Hematology, Coagulation, and Others (includes corresponding Graph/Chart)
    • Table 2: World In-Vitro Diagnostic (IVD) Market by Leading Players (2008): Market Share Breakdown for Roche, Siemens, Abbott Diagnostics, Becton Dickinson, Beckman Coulter, OCD , BioMerieux, Sysmex, and Others (includes corresponding Graph/Chart)
    • Table 3: World Molecular Diagnostics Market (2007-2015): Key Segments [Oncology, Genetic Testing, Blood Screening, and Infectious Disease Testing] Ranked by Growth (includes corresponding Graph/Chart)
  • Genetic Testing Outlook Brightens
  • Issues & Trends Affecting the Market
  • Challenges Faced
  • Genetic Counseling: Gaining Momentum
  • Online Approach Gains Momentum
  • Pediatric Genetic Testing for Screening Adult Onset Disorders Fast Gaining Acceptance
  • Recommendations of ACOG and ACGM Augments Demand for CF Testing
  • Ethical Issues & Need for Appropriate Regulating Policies
  • Routine Clinical Testing Vs. Predictive Genetic Testing
  • Issues Related to Genetic Tests for Obesity
  • Diagnosis and Treatment during Pregnancy, an Effective Way of Alleviating Syphilis Related Deaths and Stillbirths
  • Competition
    • Table 4: Leading Players in the Worldwide Genetic Testing Market (2006): Percentage Breakdown by Value Sales for Roche Diagnostics / Affymetrix, Abbott Laboratories, Bio-Rad Laboratories, and Others (includes corresponding Graph/Chart)

2. PRODUCT OVERVIEW

  • Preface to Genetic Testing
  • Genetic Testing and its Applications
  • Gene Candidate and Genome Screen
  • 'DNA Chip' to Chip into Genetic Field
  • Techniques Used to Identify Changes in Genes
  • Types of Genetic Testing
  • Steps in Genetic Testing Process
  • Limitations
  • Risks and Other Limitations of Genetic Testing
  • Medical Institutions to Reap the Benefit of Genetic Testing
  • Pharmacogenetics/Pharmacogenomics
  • Review of Select Genetic Tests
  • Cystic Fibrosis
  • Breast and Ovarian Cancer
  • Alzheimer's Disease
  • Colorectal Cancer
  • Haemochromatosis (HH)
  • Cowden Syndrome
  • Huntington's Disease
  • Costs of Select Tests
    • Table 5: Costs of Select Genetic Tests

3. PRODUCT LAUNCHES

  • Health Diagnostic Laboratory Introduces CYP2C19 Genetic Test
  • Response Genetics Introduces EML4-ALK Genetic Test
  • Roche Launches GS Junior System
  • Acton Biotech Introduces Genetic Test for Warfarin
  • Ambry Genetics Launches AmbryScreen
  • Family Tree DNA Introduces Family Finder DNA Test
  • Machaon Unveils Clinical Testing Service for Warfarin- Prescribed Patients
  • Helicos BioSciences Develops MDx Tests
  • AccessDNA Launches Telephone Based Genetic Counseling Services
  • DNA Genotek Unveils Performagene™ LIVESTOCK
  • Equinome Introduces Speed Gene Test
  • Applied Biosystems Unveils 3500 Series and 3500 DX Series Genetic Analyzer
  • Luminex Introduced New Range of Cystic Fibrosis Tests
  • Ambry Genetics Launches Whole-Genome Chromosomal Microarray Analysis
  • Myriad Genetics Introduces OnDose for Cancer Diagnosis
  • Xenomics to Introduce Innovative Gender Prediction Test
  • ParagonDx Offers Genetic Testing
  • Interleukin Genetics Unveils Bone Health Genetic Test
  • TessArae® Launches Human Genetic Disease Testing Solutions
  • IBM to Develop Nanoscale DNA Sequencer
  • Response Genetics Unveils ResponseDX: Gastric™ Genetic Test Panel
  • Axial Biotech Rolls out SCOLISCORE™ AIS Prognostic Test
  • CyGene Laboratories Launches Predictive Genetic Products in Russia
  • Cepheid Releases Xpert® BCR-ABL Monitor Test
  • Interleukin Genetics Introduces Inherent Health™ Brand of Genetic Tests
  • PGxHealth Introduces FAMILION® DCM Test
  • Correlagen Diagnostics Launches CardioGeneScan Test
  • PsoriasisDX Introduces Genetic Test for Psoriatic Arthritis

4. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER

  • Clinical Data Introduces Genetic Test for HCM
  • Iverson Genetic Diagnostics Unveils Warfarin Sensitivity Tests
  • HairDX Unveils New Test for Predicting Female Hair Loss
  • HairDX Introduces Genetic Test for Male Baldness
  • Clinical Data Introduces Pharmacogenetic Test for Clozapine
  • Seegene Launches 18-Plex Genotyping Test
  • InterGenetics Introduces Onco Vue
  • Applied Biosystems Introduces Novel DNA Technologies
  • Dabur Introduces CML Quest
  • deCODE Launches deCODE T2
  • DNAPrint Announces the Launch of Ancestry Indicator
  • Genzyme Unveils New Mutation Analysis Test
  • Orchid BioSciences Introduces New Testing Kit
  • Focus Diagnostics Introduces GenomEx(TM) Service
  • Relative Genetics Introduces Y-chromosome haplogroup Service on Web Site
  • Genzyme Unveils Upgraded CFplus Cystic Fibrosis (CF) Mutation Analysis

5. RECENT INDUSTRY ACTIVITY

  • LabCorp Acquires Orchid Cellmark
  • Quest Diagnostics Snaps Up Celera
  • Transgenomic Snaps Up Diagnostics Arm of Clinical Data
  • Transgenomic Licenses Intellectual Property from Integragen
  • Signal Genetics Collaborates with Array BioPharma
  • Genzyme Divests Genetic Testing Business
  • Fujirebio to Take over Innogenetics
  • Response Genetics Inks License Agreement with GSK
  • Response Genetics and Genetic Technologies Sign Distribution Pact
  • Thermo Fisher Scientific Inks Agreement to Acquire Finnzymes
  • Fluidigm Enters into Partnership with IntegraGen
  • Genetic Technologies Takes Over Assets of Perlegen Sciences
  • Orchid Cellmark Acquires Paternity and Immigration DNA Testing Business Division of Strand Analytical Laboratories
  • Al Borg Laboratories Acquires Majority Stake in Medical Genetics Center
  • BioReference Laboratories Takes Over Lenetix Medical Screening Laboratory
  • PerkinElmer to Acquire Signature Genomic Laboratories
  • Xenomics Changes Name to TrovaGene
  • BioServe Signs Agreement with NGC Medical
  • Roche Signs Agreement with IBM
  • DermaGenoma Merges with Developer of Dermatology Genetic Tests
  • USDA Purchases Fluidigm EP1 System
  • The Elitech Group Acquires Nanogen Assets
  • XDx and Bristol-Myers Squibb Company Signs Collaborative Agreement
  • Commonwealth Biotechnologies Divests Assets of Bioanalytical and Genetic Testing Business
  • QIAGEN Takes Over DxS
  • Perkinelmer Takes Over Genetic Screening Business of Surendra Genetic Labs
  • Interleukin Genetics Inks Licensing Agreement with LABEC Pharma
  • deCODE Genetics Inks Licensing Agreements with Celera
  • Gen-Probe Life Sciences Acquires Tepnel Life Sciences
  • ARCA Biopharma Merges with Nuvelo
  • Berkeley HeartLab Enters into Partnership with GenVault
  • CVS Collaborates with Generation Health to Expand PGx Testing
  • Oman LNG and Omani Health Ministry Ink Agreements
  • Aurora and Celera Ink Agreement to Integrate Genetic Testing
  • Interleukin Genetics Sells Assets of Alcan James Group
  • PharmaGenoma Launches HairDX Europe
  • SeqWright Collaborates with PharmaGenoma
  • PGxHealth Signs Contract with BCBSA
  • Sequenom Takes Over SensiGen
  • SCMM and PDI Sign Agreement for Sales Infrastructure
  • Interleukin Receives Approval for Sale of PST® Test in New York
  • Interleukin Receives Approval for Sale of PST® Test in New York
  • Medison Inks Agreement for Exclusive Representation of GeneXpert in Israel
  • Surelab and Ambica Launch Genetic Testing in Davao City
  • Correlagen Diagnostics Acquires Helicos® Genetic Analysis System
  • Quest to Carry out Genetic Tests on Patients at Scripps Health

6. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER

  • Biotage Sells Biosystems Division to QIAGEN
  • Pfizer Animal Health to Take Over Bovigen and Catapult Genetics
  • DNA Testing Systems Inks Agreement with DNAPrint Genomics
  • PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix
  • Hologic Acquires Third Wave
  • Dako Denmark Receives FDA Approval for TOP2A FISH pharmDx Device
  • Abbott Partners with Roche, OSI and Genentech
  • Lab21 Partners with Amgen
  • Medical Solutions Acquires Autogen Bioclear
  • Nanobac to Acquire DNAPrint Genomics
  • HairDX and Bosley Join Hands for Offering Genetic Test for Baldness
  • Nioxin Inks Agreement with HairDX
  • Orchid Cellmark Acquires ReliaGene Technologies
  • Celera Takes Over Atria Genetics
  • Roche Acquires 454 Life Sciences
  • BioServe and DNAPrint Genomics Form Strategic Alliance
  • Gentris Divests Stake in Genetic Testing Unit
  • LabCorp Announces Genetic Test Partnership for Bucindolol Prescription
  • Newsham Genetics Takes Over Monsanto Choice Genetics
  • BioServe Takes Over Genomics Collaborative
  • CytoDyn Completes Acquisition of Advanced Genetic Technologies
  • Sorenson Genomics Takes Over Identigene
  • Clinical Data Enters into a License Agreement with VCGS
  • Clinical Data Collaborates with George Washington University
  • Luminex Takes Over TM Bioscience
  • Schering-Plough Enters into a Contract with Warnex
  • Cepheid Acquires Sangtec
  • Medco Collaborates with Mayo
  • Lab21 to Offer CLDA's Genetic Test for Cardiac Channelopathy
  • Clinical Data Pockets Epidauros Biotechnologie
  • Beijing Adinovo Gene and GENDIA Ink Genetic Test Exchange Agreement
  • Genetic Technologies Forms Alliance with UTEK
  • QIAGEN Acquires Digene
  • Luminex Inks Development Licensing Agreement with Mayo Clinic

7. TECHNOLOGICAL DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER

  • New Molecular Diagnostic device to Improve Genetic Tests for Alzheimer disease
  • Deakin Clinic Offers PGD, a Sophisticated Testing for Genetic Disorders
  • New Gene Mapping Method to Enhance Identification of Haplotype Block
  • New Non-Invasive test a Better Indicator of Malignancy than the PSA Test

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (USA)
  • Abbott Molecular, Inc. (USA)
  • Applied Biosystems Inc. (USA)
  • AutoGenomics, Inc. (USA)
  • BioRad Laboratories (USA)
  • Celera Group (USA)
  • ELITech Group (France)
  • PerkinElmer, Inc. (USA)
  • Quest Diagnostics, Inc. (USA)
  • Roche Diagnostics Corp. (Switzerland)
  • Roche Molecular Diagnostics, Inc. (USA)
  • Transgenomic, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Market Analysis for Genetic Testing by Geographic Region - US, Canada, Japan, Europe and Rest of World Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for Genetic Testing by Geographic Region - US, Canada, Japan, Europe and Rest of World Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 8: World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Newborn Testing Gains Ground
    • Predictive Screening: Another Growth Area
    • Growth Prospects Aplenty in Preimplantation Genetic Diagnosis
    • Direct-to-Consumer Testing - A Growing Market
    • US Regulatory Environment
    • Genetic Testing Set for Big Boost with New Legislation
    • DNA-Based Testing to Move Beyond Research Laboratories
    • Key and Emerging Players in US
      • Genova Diagnostics
      • InterGenetics
      • Myriad Genetics, Inc.
  • B. Market Analytics
    • Table 9: US Recent Past, Current & Future Analysis for Genetic Testing by Segment-Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 10: US Historic Review for Genetic Testing by Segment-Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 11: US 15-Year Perspective for Genetic Testing by Segment-Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Key Player
      • Luminex Molecular Diagnostics
  • B. Market Analytics
    • Table 12: Canadian Recent Past, Current & Future Analysis for Genetic Testing - Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 13: Canadian Historic Review for Genetic Testing - Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 14: Japanese Recent Past, Current & Future Analysis for Genetic Testing - Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).
    • Table 15: Japanese Historic Review for Genetic Testing - Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • A Brief Overview of Legislations/Regulatory Policies in Select European Countries
    • Government Encourages Genetic Testing in UK
    • Italy
      • Top Prenatal Genetic Tests Conducted in Italy, by Volume (2004): A Recent Past Perspective
      • Top Postnatal Genetic Tests Conducted in Italy, by Volume (2004): A Recent Past Perspective
    • IMGM Laboratories GmbH (Germany) - Key Player
  • B. Market Analytics
    • Table 16: European Recent Past, Current & Future Analysis for Genetic Testing - Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).
    • Table 17: European Historic Review for Genetic Testing - Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

5. REST OF WORLD

  • A. Market Analysis
    • Asia & Latin America: The Future Market for Genetic Testing
    • Approval of Experiments on Human Embryos in New Zealand
    • Singapore Sets Guidelines for Genetic Research and Testing
  • B. Market Analytics
    • Table 18: Rest of World Market for Genetic Testing - Recent Past, Current & Future Analysis with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 19: Rest of World Market for Genetic Testing Historic Review with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top